We compared the diagnostic value of an enzyme immunoassay method for detection of gonococcal antigen in genital secretions with culture results and direct Gram stain for Neisseria gonorrhoeae in 1,171 men and 723 women attending a sexually transmitted disease clinic. When compared with culture results in men, the immunoassay provided a sensitivity of 94% and a specificity of 98% and was essentially equivalent to the urethral Gram stain. The predictive value of a positive immunoassay was 97% in men with a urethral discharge in whom the prevalence of gonorrhea was 36%, and 30% in men without urethral discharge, who had a 2% prevalence of gonorrhea (P < 0.001). The sensitivity of the immunoassay was 95% in men with and 67% in men without urethral discharge (P < 0.01). In women, the immunoassay resulted in a sensitivity of 78% and a specificity of 98% compared with cervical culture and had a significantly better sensitivity than the cervical Gram stain (78 versus 48%, P < 0.001). Analysis of patients with discrepant culture and immunoassay results suggested that most culture-negative, immunoassay-positive patients probably did not have gonorrhea. After treatment, all but 1 of 59 originally culture-and immunoassay-positive patients became negative in both tests by 3 days. Results of the immunoassay were not affected by transport or by refrigeration for up to 30 days.
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Most clinicians use either a Gram-stained smear of infected discharge or a culture for Neisseria gonorrhoeae to diagnose gonococcal infection. The Gram stain, when performed by an experienced microscopist, can be regarded as highly specific in patients with cervical and urethral infections (8) . Further, it is inexpensive and rapid. However, the sensitivity of the Gram stain reaches acceptable levels (ca. 96 to 98%) only in males with overt urethritis. In males with asymptomatic urethral infection and in cervical infection, Gram stain sensitivity, compared with that of culture, falls to ca. 40 to 60% (6, 7) .
Numerous selective media and transport systems have been developed for isolation of N. gonorrhoeae (2) . Optimally, the best of these systems probably detect close to 95% of male urethral infections and 85% of female cervical infections when a single swab specimen is collected (2, 3) . Disadvantages of culture confirmation of infection include loss of viability of gonococci under suboptimal conditions for transport or growth, lack of sensitivity after initiation of antibiotic therapy, failure to culture vancomycin-sensitive strains or other strains with fastidious growth characteristics, and a time requirement of up to 2 to 3 days before results are available (2, 3, 8) .
In (Gonozyme) for the diagnosis of gonococcal urethritis and cervicitis.
MATERIALS AND METHODS Patient population. All men and women being evaluated in the Harborview Medical Center sexually transmitted diseases (STD) clinic for a new problem customarily have urethral (men) and cervical (women) cultures for N. gonorrhoeae obtained. Over a 6-month period, clinicians were asked to submit swabs from these patients for antigen assay after Gram stains and cultures for N. gonorrhoeae had been obtained.
Specimen collection. Urethral specimens were collected by inserting a thin-shafted, calcium alginate urogenital swab (Inolex) 3 to 4 cm into the urethra. Although the manufacturer does not recommend that calcium alginate swabs be used with the Gonozyme assay, cotton-tipped urogenital swabs were not readily available when the study was initiated. The swab was withdrawn and rolled on a glass slide to prepare a Gram stain and was then streaked on each side of a biplate (see below). Finally, the swab was placed in a sterile plastic 15-ml tube containing 0.2 ml of specimen storage reagent and was forwarded to the laboratory for the immunoassay. In women, the exocervix was cleaned with a large cotton swab to remove adherent vaginal fluid and mucus. A cottontipped swab was then inserted into the os, rotated once, and removed. As with men, the swab was used to Immunoassay (Gonozyme) method. Specimen dilution buffer (1 ml) was added to each specimen tube, and the swabs were soaked for 2 to 5 min. The swabs were then vigorously twirled in the diluent for 15 s and discarded. Of each specimen, 200 ptl was added to wells in the enzyme immunoassay reaction tray, and an antibody-coated bead was placed in each well. Negative and positive controls were run concurrently. The tray was covered and incubated for 15 min in a 37°C water bath. A semiautomatic washing device (Pentawash; Abbott Laboratories) was used to remove unbound material from the beads. Next, 200 ,ul of rabbit antibody to N. gonorrhoeae was added to each well, and the reaction trays were incubated and the beads were washed as described above. Goat-anti-rabbit immunoglobulin G antibody-horseradish peroxidase conjugate (200 RI1) was added to each well, followed by incubation and washing. The beads were then transferred to polystyrene tubes (12 by 75 mm), and 300 ,u1 of O-phenylenediamine-2 HCl reagent was added to each tube and to a blank tube. After a 10-min incubation at room temperature in the dark, 1 ml of 1 N HCl was added to stop the reaction. Within 10 min, the optical density (OD) of the samples was read at 492 nm by using a spectrophotometer (Quantum; Abbott Laboratories).
The run was considered valid when the mean of three negative control samples (N) was less than 0.080 and the difference between the positive control and N was .0.500. N was subtracted from the OD of each sample, and this corrected value (ODc) was used as a final report. ODc values greater than or equal to 0.19 in women and greater than or equal to 0.45 in men were considered positive for N. gonorrhoeae. Cervical samples for which the ODc value ranged between 0.16 and 0.22 were reassayed within 1 day.
RESULTS
Comparison of the immunoassay with cultures for N. gonorrhoeae. Of 1,171 men screened in an STD clinic, 187 had urethral infection with N. gonorrhoeae (prevalence, 16%). Since 94% of the culture-positive men were found to have an immunoassay characterized by an ODc of 0.45 or greater, while 98% of the culture-negative men had an ODc less than 0.45, this criterion for a positive assay was judged optimal in discriminating culture-positive and culture-negative men (Fig. 1) . At ODc values of less than 0.45, the specificity of the assay fell (Fig. 1) . Compared with culture, immunoassay thus resulted in an overall sensitivity of 94%, a specificity of 98%, and a predictive value for a positive test (PVP) of 90% (Table 1) . When men were divided into those with and without a urethral discharge upon examination, the sensitivity, specificity, and PVP of the immunoassay all exceeded 95% in those with a discharge (Table 2 ) but the sensitivity (67%) and PVP (30%) were significantly reduced in those without a discharge ( Table 2) .
Of 723 women seen in the clinic, 109 had cervical infection with N. gonorrhoeae (prevalence, 15%). In women, the optimal criterion for a positive test was judged an ODc of greater than or equal to 0.19 (Fig. 2) . With this criterion, the immunoassay resulted in a sensitivity of 78% and a specificity of 98% when compared with culture results (Table 1) . If an ODc of greater than 0.19 was used to define a positive test, the sensitivity of the assay was less (Fig. 2) . Women whose initial ODc reading fell within the range 0.16 to 0.22 were retested and then reclassified based upon this second reading. Retesting of borderline specimens improved the PVP to 88 from 85% in women, without diminishing the predictive value of a negative test (96% before and after retest).
In 31 men and 39 women, the cultures for N. gonorrhoeae and the immunoassay provided discrepant results. To gain additional insight into whether these patients actually had infection with N. gonorrhoeae, clinical and epidemiological data were examined (Table 3) . Among 12 men who were culture positive but immunoassay negative, 6 of 9 tested had positive Gram stains, 3 of 12 were contacts to known gonorrhea cases, and 9 of the 12 had urethritis upon exami- nation, suggesting that these men indeed had gonorrhea, not false-positive cultures. In contrast, of 19 immunoassaypositive but culture-negative men, only 2 of the 16 tested had Gram stains that were interpreted as positive for gonococci, none were known contacts to gonorrhea, and only 5 of 19 had urethritis upon examination. Thus, 17 of these 19 patients had little evidence of gonococcal infection and probably represented false-positive immunoassays, whereas 2 patients most likely had false-negative cultures. Similar analyses for women also suggested that most immunoassaypositive, culture-negative patients did not have gonorrhea (Table 3) .
Comparison (Table 4 ). In women, the immunoassay exhibited a significantly greater sensitivity (78%) than the cervical Gram stain (48%) when both tests were compared with cervical cultures (Table 4 ; P < 0.01). No false-positive tests occurred by Gram stain, whereas the immunoassay had a specificity of 98%.
Use of the immunoassay for test-of-cure evaluation. A total of 24 men who were originally positive by both urethral culture and immunoassay were retested 4 to 17 days after antibiotic treatment for their N. gonorrhoeae infection. All 24 were culture negative and immunoassay negative. Of 15 women who were similarly retested 3 to 5 days after treatment, all had become negative both by culture and immunoassay.
To more carefully evaluate the immunoassay as a means of assessing test of cure after treatment, 10 men and 10 women originally positive by both immunoassay and culture were followed on a daily basis until both tests became negative. Of 10 men, 7 were both culture negative and immunoassay negative at posttreatment day 1, whereas 2 men were culture negative at day 1 but did not become immunoassay negative until day 2. One patient had persistently positive immunoassays despite negative cultures for 5 days after treatment, after which the assay became negative. In the 10 women tested, all were culture negative on posttreatment day 1, and the immunoassay was negative by posttreatment day 2 in all cases.
Effect of transport. After transport and refrigeration of from 5 to 30 days, the sensitivity and specificity of the immunoassay for both male urethral and female cervical specimens did not differ appreciably from nontransported specimens run within 72 h of collection (Table 5) .
DISCUSSION
How might new diagnostic tests for gonorrhea improve upon currently available methods? For symptomatic men, the Gram stain is an inexpensive, rapid, and accurate test when performed by experienced personnel (8) . In asymptomatic men, however, Gram stain sensitivity falls to 40% when compared with culture, and another test might be useful (6, 7) . In women with cervical gonorrhea, the nonspecificity of symptoms and signs of infection and the relatively poor sensitivity of the cervical Gram stain for gonorrhea make rapid diagnosis difficult. If one awaits culture results before providing treatment, a delay of 2 to 3 days or longer may occur. During this delay, complications such as salpingitis may ensue, or gonorrhea may be transmitted to additional sex partners. A rapid diagnostic test more sensitive (2, 3) . In women, the sensitivity of a single endocervical culture approximates 85%, and room for improvement clearly exists (2, 3) . Finally, currently available transport systems could probably be improved upon, since these systems do not support survival of gonococci for long periods (2, 3, 8) .
Antigen detection provides some of the features cited above. The immunoassay is more rapid than culture. The assay itself requires ca. 1 h to perform, but specimens are usually run in groups, not individually. Thus, one or two runs per day, depending on the number of patients seen, would provide results on the same day as the patient was seen in the clinic. Infected patients could be asked to return the same day for treatment rather than calling several days later. The assay cannot, however, be done rapidly enough to provide results before the patient leaves the clinic and is thus not equivalent in speed to the Gram stain. That the antigen remains stable over days with simple refrigeration also makes it a marked improvement over currently available transport systems.
Our results suggest that the immunoassay would facilitate more rapid diagnosis of gonorrhea in women because the cervical Gram stain has inadequate sensitivity and cultures require days to complete. The immunoassay has less utility in men attending STD clinics because of the high sensitivity of the urethral Gram stain and because most men (93% in our study) with gonorrhea in an STD clinic have symptomatic urethritis. In other patient care settings in which a higher proportion of men with gonorrhea would be expected to be asymptomatic or where specimens for culture or Gram stain are routinely transported to a referral laboratory, an immunoassay would be of greater potential value. However, we found the sensitivity and PVP of the immunoassay to be lowest (67 and 30%, respectively) among men without urethral discharge in whom the prevalence of gonorrhea was only 2%. These results are in accord with Bayes Theorem, which states that unless a test exhibits perfect specificity, its PVP will decline rapidly as the prevalence of the disease in the test population declines. In addition, patients with asymptomatic gonorrhea presumably have fewer gonococci and hence less antigen per swab. We used each swab for making a Gram stain and for streaking a biplate before using J. CLIN. MICROBIOL.
on January 19, 2018 by guest http://jcm.asm.org/ Downloaded from it for antigen assay; loss of antigen during these steps may have been a factor in patients with few organisms to begin with. Further evaluation of the immunoassay in low-risk populations should be undertaken to assess its value for screening in this setting.
We have not tested the immunoassay for diagnosis of rectal or pharyngeal specimens. Since most laboratories would doubtlessly prefer to use a single diagnostic test for all potential sites of infection, the immunoassay needs to be studied further with regard to these sites. Our experience also suggests that other variables such as the type of swab used to collect specimens can influence the results obtained; further use of the assay will clarify the importance of such factors and define optimal circumstances for its use.
